NEW YORK (Reuters Health) – Augmenting antipsychotic treatment with citalopram can reduce suicidal ideation in schizophrenic patients with subthreshold depressive symptoms, a new study shows. And among patients…
NEW YORK (Reuters Health) – The anticonvulsant topiramate (Topamax) helps treat alcohol dependence, but serious side effects might limit its use, researchers say. In their systematic review, Dr.…
NEW YORK (Reuters Health) – In treating social anxiety disorder, phenelzine combined with cognitive behavioral group therapy achieves a higher response rates than either treatment alone or placebo,…
Joshua Grill, PhD, Director, Katherine and Benjamin Kagan Alzheimer’s Disease Treatment Development Program, UCLA, Alzheimer’s Disease, which is currently a worldwide healthcare crisis and it is expected to…
Ian A Cook, MD, Director of Unipolar Depression Research, UCLA David Geffen School of Medicine, discusses new treatment options for depression, particularly deep brain stimulation and injectable treatment…
NEW YORK (Reuters Health) – Use of paroxetine during tamoxifen therapy reduces the breast cancer survival benefit by 25% or more depending on the amount of time the…
NEW YORK (Reuters Health) – In patients with schizophrenia, clozapine does not seem to increase the risk of cardiovascular death relative to risperidone, despite known differences in cardiometabolic…
NEW YORK (Reuters Health) – Stimulant medications show greater efficacy than nonstimulants for treating attention-deficit/hyperactivity disorder (ADHD) in adults, according to a new meta-analysis. Study authors Dr. Stephen…
Gary Small, MD, Director, UCLA Center on Aging, University of California, Los Angeles, discusses a recent study, “Your Brain on Google” in which blood flow patterns were compared…
Joshua Grill, PhD, Director, Katherine and Benjamin Kagan Alzheimer’s Disease Treatment Development Program, UCLA, discusses new therapies for Alzheimer’s Disease. The FDA has currently approved 5 symptomatic therapies…